植物由来ワクチンの世界市場研究

• 英文タイトル:Market Study on Plant-based Vaccines: North America Leads with Over One-third Market Share

Market Study on Plant-based Vaccines: North America Leads with Over One-third Market Share「植物由来ワクチンの世界市場研究」(市場規模、市場予測)調査レポートです。• レポートコード:MRC2301E003
• 出版社/出版日:Persistence Market Research / 2022年10月19日
• レポート形態:英文、PDF、250ページ
• 納品方法:Eメール
• 産業分類:バイオ
• 販売価格(消費税別)
  Single User¥735,000 (USD4,900)▷ お問い合わせ
  Site Licence¥1,140,000 (USD7,600)▷ お問い合わせ
  Enterprisewide¥1,590,000 (USD10,600)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
Persistence Market Research社の本調査レポートは、世界の植物由来ワクチン市場の現状について調査しています。本レポートでは、エグゼクティブサマリー、市場概要、主要市場動向、主要成功要因、市場背景、新型コロナウイルス感染症危機分析、需要分析・予測、ソース別(トウモロコシ、タバコ、じゃがいも、その他)分析、種類別(ウイルスワクチン、細菌ワクチン、その他)分析、用途別(インフルエンザ、ジカウイルス、エボラウイルス、その他)分析、地域別(北米、中南米、ヨーロッパ、東アジア、南アジア、オセアニア、中東・アフリカ)分析、構造分析、競争分析、仮定、調査方法などをまとめております。本レポートには、Creative Biolabs、Medicago Inc.、iBio、ICON、EEA Consulting Engineers、Kentucky BioProcessing, Incなどの企業情報が含まれています。
・エグゼクティブサマリー
・市場概要
・主要市場動向
・主要成功要因
・市場背景
・新型コロナウイルス感染症危機分析
・需要分析・予測
・世界の植物由来ワクチン市場規模:ソース別
- トウモロコシ由来ワクチンの市場規模
- タバコ由来ワクチンの市場規模
- じゃがいも由来ワクチンの市場規模
- その他の市場規模
・世界の植物由来ワクチン市場規模:種類別
- ウイルスワクチンにおける市場規模
- 細菌ワクチンにおける市場規模
- その他における市場規模
・世界の植物由来ワクチン市場規模:用途別
- インフルエンザ用植物由来ワクチンの市場規模
- ジカウイルス用植物由来ワクチンの市場規模
- エボラウイルス用植物由来ワクチンの市場規模
- その他の市場規模
・世界の植物由来ワクチン市場規模:地域別
- 北米の植物由来ワクチン市場規模
- 中南米の植物由来ワクチン市場規模
- ヨーロッパの植物由来ワクチン市場規模
- 東アジアの植物由来ワクチン市場規模
- 南アジアの植物由来ワクチン市場規模
- オセアニアの植物由来ワクチン市場規模
- 中東・アフリカの植物由来ワクチン市場規模
・構造分析
・競争分析
・仮定
・調査方法

Plant-based Vaccines Market: Scope of Report

The latest publication by Persistence Market Research on the global plant-based vaccines market evaluates the opportunities and current market landscape and provides detailed analysis and updates about corresponding sections affecting the market. The study offers detailed insights into current market dynamics, which include the drivers, restraints, trends, and opportunities in the market. The principal aim of the market study is to present exclusive information about how the market will perform during the forecast period of 2022-2032.

Important indicators for the successful growth of the market are presented in this comprehensive report, which includes a Year-on-Year (Y-o-Y) growth analysis of the market, and compounded annual growth rate (CAGR), which are described exhaustively in Persistence Market Research’s study. This research study can support readers in knowing the demand for plant-based vaccines product and the quantitative development opportunities during the study period.

The research is beneficial for shareholders in the landscape, including investors, manufacturers, service providers, distributors, and suppliers, and can help them in developing suitable business strategies to flourish in the plant-based vaccines market. Insights and information presented in this Persistence Market Research study can be leveraged by shareholders in the plant-based vaccines market, industry experts, investors, researchers, and reporters, as well as business enthusiasts.

Market statistics, as well as information linked to the macro- as well as macroeconomic variables affecting the business scenario in the plant-based vaccines market, are also included in the current study. Depending on potential developments in the market, substantive insights are also encountered in this report. Additionally, by the data submitted in this report, minor companies and new entrants in the industry can be aided in making suitable company choices to achieve traction in the market.

Key Market Segments

Persistence Market Research’s study on the plant-based vaccines market offers information divided into four important segments – type, source, application, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

Type

Viral Vaccines
Bacterial Vaccines
Others
Source

Maize
Tobacco
Potatoes
Others
Application

Influenza
Zika Virus
Ebola Virus
Others
Region

North America
Latin America
Europe
East Asia
South Asia
Oceania
Middle East and Africa
Key Questions Answered in Report

Which regions will continue to remain the most profitable markets for plant-based vaccines over the coming years?
How will changing trends influence the market?
How has the COVID-19 crisis influenced market growth?
How can market players capture the low-hanging opportunities in developed regions?
What are the strategies of stakeholders in the market to shape their position in this landscape?
What are the restraining factors that investors need to be aware of and might tackle while investing in the market?
What are the developmental trends that will influence the market?
How can companies in the plant-based vaccines market avail themselves of the growth opportunities in developed and emerging sectors?
Research Methodology

In Persistence Market Research’s study, a unique research methodology is utilized to conduct extensive research on the growth of the plant-based vaccines market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts to ensure the accuracy and reliability of the conclusions.

Secondary resources referred to by analysts during the production of the market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.

Comprehensive information acquired from primary and secondary resources acts as validation from companies in the market and makes Persistence Market Research’s projections on the growth prospects of the plant-based vaccines market are more accurate and reliable.

レポート目次

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

    2.3. Inclusions and Exclusions

3. Key Market Trends

    3.1. Key Trends Impacting the Market

    3.2. Market Innovation / Development Trends

4. Key Success Factors

    4.1. Promotional Strategies, By Key Manufacturers

    4.2. Key Regulations

    4.3. Product Pipeline

    4.4. Reimbursement Scenario

    4.5. Value Chain Analysis

    4.6. PESTEL Analysis

    4.7. Porter’s Analysis

5. Market Background

    5.1. Macro-Economic Factors

        5.1.1. Global GDP Growth Outlook

        5.1.2. Global Healthcare Expenditure Outlook

        5.1.3. Global Recombinant Vaccines Market Outlook

    5.2. Forecast Factors – Relevance & Impact

        5.2.1. Cost of Production

        5.2.2. Growing Development of Recombinant Vaccines

        5.2.3. Increasing Incidence of Zoonotic Diseases

        5.2.4. Rising Research and Development Activities

        5.2.5. Growing Marketing Approvals for Plant-Based Vaccines

        5.2.6. Cost of Vaccines

        5.2.7. Emergence of the COVID-19 Pandemic

        5.2.8. Large Clinical Pipeline

    5.3. Market Dynamics

        5.3.1. Drivers

        5.3.2. Restraints

        5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

    6.1. COVID-19 and Impact Analysis

        6.1.1. By Source

        6.1.2. By Type

        6.1.3. By Application

        6.1.4. By Country

    6.2. 2021 Market Scenario

7. Global Plant-Based Vaccines Market Demand (in Value or Size in US$ Mn) Analysis 2012–2021 and Forecast, 2022–2032

    7.1. Historical Market Value (US$ Mn) Analysis, 2012-2021

    7.2. Current and Future Market Value (US$ Mn) Projections, 2022–2032

        7.2.1. Y-o-Y Growth Trend Analysis

        7.2.2. Absolute $ Opportunity Analysis

8. Global Plant-Based Vaccines Market Analysis 2012-2021 and Forecast 2022–2032, By Source

    8.1. Introduction / Key Findings

    8.2. Historical Market Size (US$ Mn) Analysis By Source, 2012 – 2021

    8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Source, 2022 – 2032

        8.3.1. Maize

        8.3.2. Tobacco

        8.3.3. Potato

        8.3.4. Others

    8.4. Market Attractiveness Analysis By Source

9. Global Plant-Based Vaccines Market Analysis 2012-2021 and Forecast 2022–2032, By Type

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$ Mn) Analysis By Type , 2012 – 2021

    9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Type, 2022 – 2032

        9.3.1. Viral Vaccine

        9.3.2. Bacterial Vaccine

        9.3.3. Others

    9.4. Market Attractiveness Analysis By Type

10. Global Plant-Based Vaccines Market Analysis 2012-2021 and Forecast 2022–2032, By Application

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Mn) Analysis By Application, 2012 – 2021

    10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2022 – 2032

        10.3.1. Influenza

        10.3.2. Zika Virus

        10.3.3. Ebola Virus

        10.3.4. Others

    10.4. Market Attractiveness Analysis By Application

11. Global Plant-Based Vaccines Market Analysis 2012-2021 and Forecast 2022–2032, By Region

    11.1. Introduction / Key Findings

    11.2. Historical Market Size (US$ Mn) Analysis By Region, 2012-2021

    11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2022–2032

        11.3.1. North America

        11.3.2. Latin America

        11.3.3. Europe

        11.3.4. East Asia

        11.3.5. South Asia

        11.3.6. Oceania

        11.3.7. Middle East and Africa

    11.4. Market Attractiveness Analysis By Region

12. North America Plant-Based Vaccines Market Analysis 2012–2021 and Forecast 2022–2032

    12.1. Introduction

    12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2012–2021

    12.3. Current and Future Market Size (US$ Mn) Analysis & Forecast By Market Taxonomy, 2022–2032

        12.3.1. By Country

            12.3.1.1. U.S.

            12.3.1.2. Canada

        12.3.2. By Source

        12.3.3. By Type

        12.3.4. By Application

    12.4. Market Attractiveness Analysis

        12.4.1. By Country

        12.4.2. By Source

        12.4.3. By Type

        12.4.4. By Application

    12.5. Market Trends

    12.6. Key Market Participants – Intensity Mapping

    12.7. Drivers and Restraints – Impact Analysis

    12.8. Country Level Analysis & Forecast

        12.8.1. U.S. Plant-Based Vaccines Market Analysis

            12.8.1.1. Introduction

            12.8.1.2. Market Analysis and Forecast By Market Taxonomy

                12.8.1.2.1. By Country

                12.8.1.2.2. By Source

                12.8.1.2.3. By Type

                12.8.1.2.4. By Application

        12.8.2. Canada Plant-Based Vaccines Market Analysis

            12.8.2.1. Introduction

            12.8.2.2. Market Analysis and Forecast By Market Taxonomy

                12.8.2.2.1. By Country

                12.8.2.2.2. By Source

                12.8.2.2.3. By Type

                12.8.2.2.4. By Application

13. Latin America Plant-Based Vaccines Market Analysis 2012–2021 and Forecast 2022–2032

    13.1. Introduction

    13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2012–2021

    13.3. Current and Future Market Size (US$ Mn) Analysis & Forecast By Market Taxonomy, 2022–2032

        13.3.1. By Country

            13.3.1.1. Mexico

            13.3.1.2. Brazil

            13.3.1.3. Argentina

            13.3.1.4. Rest of Latin America

                13.3.1.4.1. By Country

                13.3.1.4.2. By Source

                13.3.1.4.3. By Type

                13.3.1.4.4. By Application

    13.4. Market Attractiveness Analysis

        13.4.1. By Country

        13.4.2. By Source

        13.4.3. By Type

        13.4.4. By Application

    13.5. Market Trends

    13.6. Key Market Participants – Intensity Mapping

    13.7. Drivers and Restraints – Impact Analysis

    13.8. Country Level Analysis & Forecast

        13.8.1. Mexico Plant-Based Vaccines Market Analysis

            13.8.1.1. Introduction

            13.8.1.2. Market Analysis and Forecast By Market Taxonomy

                13.8.1.2.1. By Source

                13.8.1.2.2. By Type

                13.8.1.2.3. By Application

        13.8.2. Brazil Plant-Based Vaccines Market Analysis

            13.8.2.1. Introduction

            13.8.2.2. Market Analysis and Forecast By Market Taxonomy

                13.8.2.2.1. By Country

                13.8.2.2.2. By Source

                13.8.2.2.3. By Type

                13.8.2.2.4. By Application

        13.8.3. Argentina Plant-Based Vaccines Market Analysis

            13.8.3.1. Introduction

            13.8.3.2. Market Analysis and Forecast By Market Taxonomy

                13.8.3.2.1. By Source

                13.8.3.2.2. By Type

                13.8.3.2.3. By Application

14. Europe Plant-Based Vaccines Market Analysis 2012–2021 and Forecast 2022–2032

    14.1. Introduction

    14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2012–2021

    14.3. Current and Future Market Size (US$ Mn) Analysis & Forecast By Market Taxonomy, 2022–2032

        14.3.1. By Country

            14.3.1.1. Germany

            14.3.1.2. Italy

            14.3.1.3. France

            14.3.1.4. U.K.

            14.3.1.5. Spain

            14.3.1.6. BENELUX

            14.3.1.7. Russia

            14.3.1.8. Rest of Europe

        14.3.2. By Source

        14.3.3. By Type

        14.3.4. By Application

    14.4. Market Attractiveness Analysis

        14.4.1. By Country

        14.4.2. By Source

        14.4.3. By Type

        14.4.4. By Application

    14.5. Market Trends

    14.6. Key Market Participants – Intensity Mapping

    14.7. Drivers and Restraints – Impact Analysis

    14.8. Country Level Analysis & Forecast

        14.8.1. Germany Plant-Based Vaccines Market Analysis

            14.8.1.1. Introduction

            14.8.1.2. Market Analysis and Forecast By Market Taxonomy

                14.8.1.2.1. By Source

                14.8.1.2.2. By Type

                14.8.1.2.3. By Application

        14.8.2. Italy Plant-Based Vaccines Market Analysis

            14.8.2.1. Introduction

            14.8.2.2. Market Analysis and Forecast By Market Taxonomy

                14.8.2.2.1. By Source

                14.8.2.2.2. By Type

                14.8.2.2.3. By Application

        14.8.3. France Plant-Based Vaccines Market Analysis

            14.8.3.1. Introduction

            14.8.3.2. Market Analysis and Forecast By Market Taxonomy

                14.8.3.2.1. By Source

                14.8.3.2.2. By Type

                14.8.3.2.3. By Application

        14.8.4. U.K. Plant-Based Vaccines Market Analysis

            14.8.4.1. Introduction

            14.8.4.2. Market Analysis and Forecast By Market Taxonomy

                14.8.4.2.1. By Source

                14.8.4.2.2. By Type

                14.8.4.2.3. By Application

        14.8.5. Spain Plant-Based Vaccines Market Analysis

            14.8.5.1. Introduction

            14.8.5.2. Market Analysis and Forecast By Market Taxonomy

                14.8.5.2.1. By Source

                14.8.5.2.2. By Type

                14.8.5.2.3. By Application

        14.8.6. BENELUX Plant-Based Vaccines Market Analysis

            14.8.6.1. Introduction

            14.8.6.2. Market Analysis and Forecast By Market Taxonomy

                14.8.6.2.1. By Source

                14.8.6.2.2. By Type

                14.8.6.2.3. By Application

        14.8.7. Russia Plant-Based Vaccines Market Analysis

            14.8.7.1. Introduction

            14.8.7.2. Market Analysis and Forecast By Market Taxonomy

                14.8.7.2.1. By Source

                14.8.7.2.2. By Type

                14.8.7.2.3. By Application

15. East Asia Plant-Based Vaccines Market Analysis 2012–2021 and Forecast 2022–2032

    15.1. Introduction

    15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2012–2021

    15.3. Current and Future Market Size (US$ Mn) Analysis & Forecast By Market Taxonomy, 2022–2032

        15.3.1. By Country

            15.3.1.1. China

            15.3.1.2. Japan

            15.3.1.3. South Korea

        15.3.2. By Source

        15.3.3. By Type

        15.3.4. By Application

    15.4. Market Attractiveness Analysis

        15.4.1. By Country

        15.4.2. By Source

        15.4.3. By Type

        15.4.4. By Application

    15.5. Market Trends

    15.6. Key Market Participants – Intensity Mapping

    15.7. Drivers and Restraints – Impact Analysis

    15.8. Country Level Analysis & Forecast

        15.8.1. China Plant-Based Vaccines Market Analysis

            15.8.1.1. Introduction

            15.8.1.2. Market Analysis and Forecast By Market Taxonomy

                15.8.1.2.1. By Source

                15.8.1.2.2. By Type

                15.8.1.2.3. By Application

        15.8.2. Japan Plant-Based Vaccines Market Analysis

            15.8.2.1. Introduction

            15.8.2.2. Market Analysis and Forecast By Market Taxonomy

                15.8.2.2.1. By Source

                15.8.2.2.2. By Type

                15.8.2.2.3. By Application

        15.8.3. South Korea Plant-Based Vaccines Market Analysis

            15.8.3.1. Introduction

            15.8.3.2. Market Analysis and Forecast By Market Taxonomy

                15.8.3.2.1. By Source

                15.8.3.2.2. By Type

                15.8.3.2.3. By Application

16. South Asia Plant-Based Vaccines Market Analysis 2012–2021 and Forecast 2022–2032

    16.1. Introduction

    16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2012–2021

    16.3. Current and Future Market Size (US$ Mn) Analysis & Forecast By Market Taxonomy, 2022–2032

        16.3.1. By Country

            16.3.1.1. India

            16.3.1.2. Indonesia

            16.3.1.3. Malaysia

            16.3.1.4. Thailand

            16.3.1.5. Rest of South Asia

        16.3.2. By Source

        16.3.3. By Type

        16.3.4. By Application

    16.4. Market Attractiveness Analysis

        16.4.1. By Country

        16.4.2. By Source

        16.4.3. By Type

        16.4.4. By Application

    16.5. Market Trends

    16.6. Key Market Participants – Intensity Mapping

    16.7. Drivers and Restraints – Impact Analysis

    16.8. Country Level Analysis & Forecast

        16.8.1. India Plant-Based Vaccines Market Analysis

            16.8.1.1. Introduction

            16.8.1.2. Market Analysis and Forecast By Market Taxonomy

                16.8.1.2.1. By Source

                16.8.1.2.2. By Type

                16.8.1.2.3. By Application

        16.8.2. Indonesia Plant-Based Vaccines Market Analysis

            16.8.2.1. Introduction

            16.8.2.2. Market Analysis and Forecast By Market Taxonomy

                16.8.2.2.1. By Source

                16.8.2.2.2. By Type

                16.8.2.2.3. By Application

        16.8.3. Malaysia Plant-Based Vaccines Market Analysis

            16.8.3.1. Introduction

            16.8.3.2. Market Analysis and Forecast By Market Taxonomy

                16.8.3.2.1. By Source

                16.8.3.2.2. By Type

                16.8.3.2.3. By Application

        16.8.4. Thailand Plant-Based Vaccines Market Analysis

            16.8.4.1. Introduction

            16.8.4.2. Market Analysis and Forecast By Market Taxonomy

                16.8.4.2.1. By Source

                16.8.4.2.2. By Type

                16.8.4.2.3. By Application

17. Oceania Plant-Based Vaccines Market 2012-2021 and Forecast 2022-2032

    17.1. Introduction

    17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2012–2021

    17.3. Current and Future Market Size (US$ Mn) Analysis & Forecast By Market Taxonomy, 2022–2032

        17.3.1. By Country

            17.3.1.1. Australia

            17.3.1.2. New Zealand

        17.3.2. By Source

        17.3.3. By Type

        17.3.4. By Application

    17.4. Market Attractiveness Analysis

        17.4.1. By Country

        17.4.2. By Source

        17.4.3. By Type

        17.4.4. By Application

    17.5. Key Market Participants – Intensity Mapping

    17.6. Drivers and Restraints – Impact Analysis

    17.7. Country Level Analysis & Forecast

        17.7.1. Australia Plant-Based Vaccines Market Analysis

            17.7.1.1. Introduction

            17.7.1.2. Market Analysis and Forecast By Market Taxonomy

                17.7.1.2.1. By Source

                17.7.1.2.2. By Type

                17.7.1.2.3. By Application

        17.7.2. New Zealand Plant-Based Vaccines Market Analysis

            17.7.2.1. Introduction

            17.7.2.2. Market Analysis and Forecast By Market Taxonomy

                17.7.2.2.1. By Source

                17.7.2.2.2. By Type

                17.7.2.2.3. By Application

18. Middle East and Africa (MEA) Plant-Based Vaccines Market Analysis 2012–2021 and Forecast 2022–2032

    18.1. Introduction

    18.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2012–2021

    18.3. Current and Future Market Size (US$ Mn) Analysis & Forecast By Market Taxonomy, 2022–2032

        18.3.1. By Country

            18.3.1.1. GCC Countries

            18.3.1.2. Turkey

            18.3.1.3. South Africa

            18.3.1.4.  North Africa

            18.3.1.5. Rest of Middle East and Africa

        18.3.2. By Source

        18.3.3. By Type

        18.3.4. By Application

    18.4. Market Attractiveness Analysis

        18.4.1. By Country

        18.4.2. By Source

        18.4.3. By Type

        18.4.4. By Application

    18.5. Market Trends

    18.6. Key Market Participants – Intensity Mapping

    18.7. Drivers and Restraints – Impact Analysis

    18.8. Country Level Analysis & Forecast

        18.8.1. GCC Countries Plant-Based Vaccines Market Analysis

            18.8.1.1. Introduction

            18.8.1.2. Market Analysis and Forecast By Market Taxonomy

                18.8.1.2.1. By Source

                18.8.1.2.2. By Type

                18.8.1.2.3. By Application

        18.8.2. Turkey Plant-Based Vaccines Market Analysis

            18.8.2.1. Introduction

            18.8.2.2. Market Analysis and Forecast By Market Taxonomy

                18.8.2.2.1. By Source

                18.8.2.2.2. By Type

                18.8.2.2.3. By Application

        18.8.3. South Africa Plant-Based Vaccines Market Analysis

            18.8.3.1. Introduction

            18.8.3.2. Market Analysis and Forecast By Market Taxonomy

                18.8.3.2.1. By Source

                18.8.3.2.2. By Type

                18.8.3.2.3. By Application

        18.8.4. North Africa Plant-Based Vaccines Market Analysis

            18.8.4.1. Introduction

            18.8.4.2. Market Analysis and Forecast By Market Taxonomy

                18.8.4.2.1. By Source

                18.8.4.2.2. By Type

                18.8.4.2.3. By Application

19. Market Structure Analysis

    19.1. Market Analysis By Tier of Companies

    19.2. Market Concentration

    19.3. Market Share Analysis (%) of Top Players

    19.4. Market Presence Analysis

20. Competition Analysis

    20.1. Competition Dashboard

    20.2. Competition Benchmarking

    20.3. Competition Deep Dive

        20.3.1. Creative Biolabs

            20.3.1.1. Overview

            20.3.1.2. Product Portfolio

            20.3.1.3. Sales Footprint

            20.3.1.4. Key Financials

            20.3.1.5. SWOT Analysis

            20.3.1.6. Strategic Overview

        20.3.2. Medicago Inc.

            20.3.2.1. Overview

            20.3.2.2. Product Portfolio

            20.3.2.3. Sales Footprint

            20.3.2.4. Key Financials

            20.3.2.5. SWOT Analysis

            20.3.2.6. Strategic Overview

        20.3.3. iBio

            20.3.3.1. Overview

            20.3.3.2. Product Portfolio

            20.3.3.3. Sales Footprint

            20.3.3.4. Key Financials

            20.3.3.5. SWOT Analysis

            20.3.3.6. Strategic Overview

        20.3.4. ICON

            20.3.4.1. Overview

            20.3.4.2. Product Portfolio

            20.3.4.3. Sales Footprint

            20.3.4.4. Key Financials

            20.3.4.5. SWOT Analysis

            20.3.4.6. Strategic Overview

        20.3.5. EEA Consulting Engineers

            20.3.5.1. Overview

            20.3.5.2. Product Portfolio

            20.3.5.3. Sales Footprint

            20.3.5.4. Key Financials

            20.3.5.5. SWOT Analysis

            20.3.5.6. Strategic Overview

        20.3.6. Kentucky BioProcessing, Inc.

            20.3.6.1. Overview

            20.3.6.2. Product Portfolio

            20.3.6.3. Sales Footprint

            20.3.6.4. Key Financials

            20.3.6.5. SWOT Analysis

            20.3.6.6. Strategic Overview

        20.3.7. Baiya Phytopharm

            20.3.7.1. Overview

            20.3.7.2. Product Portfolio

            20.3.7.3. Sales Footprint

            20.3.7.4. Key Financials

            20.3.7.5. SWOT Analysis

            20.3.7.6. Strategic Overview

        20.3.8. Protalix Biotherapeutics

            20.3.8.1. Overview

            20.3.8.2. Product Portfolio

            20.3.8.3. Sales Footprint

            20.3.8.4. Key Financials

            20.3.8.5. SWOT Analysis

            20.3.8.6. Strategic Overview

21. Assumptions and Acronyms Used

22. Research Methodology




• 英文レポート名:Market Study on Plant-based Vaccines: North America Leads with Over One-third Market Share
• 日本語訳:植物由来ワクチンの世界市場研究
• レポートコード:MRC2301E003お問い合わせ(見積依頼・ご注文・質問)